PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons

Related Articles
Microbiome: Expanding the Gut Gene Catalog
November 2014
Complex Search
September 2014
Repairing a Rift
September 2014
iTRAQing the Ubiquitinome
July 2014
Immunity: Clustering Immunoglobulins
June 2014
Mining Protein Dynamics
May 2014
Design and Discovery: Identifying New Enzymes and Metabolic Pathways
January 2014
Epigenetics: Tracing Histone Demethylase Inhibitors
December 2013
Cancer Networks: Predicting Catalytic Residues from 3D Protein Structures
November 2013
Protein-Nucleic Acid Interaction: Inhibition Through Allostery
July 2013
Infectious Diseases: Targeting Meningitis
May 2013
Protein Interaction Networks: Reading Between the Lines
April 2013
Design and Discovery: A Cocktail for Proteins Without ID
February 2013
Targeting Enzyme Function with Structural Genomics
July 2012
More in one
June 2012
Disordered Proteins
February 2012
RNA Chaperone NMB1681
July 2011
Capsid assembly in motion
April 2011
One at a time
April 2011
A growing family
February 2011
Predicting functions within a superfamily
January 2011
Isoxanthopterin Deaminase
November 2010
Scaling up mutational scanning
November 2010
Alpha/Beta Barrels
October 2010
Mre11 Nuclease
May 2010
Assigning protein function: GeMMA
April 2010
Face off
October 2009

Technology Topics Annotation/Function

iTRAQing the Ubiquitinome

SBKB [doi:10.1038/sbkb.2014.211]
Technical Highlight - July 2014
Short description: An inflammatory signal triggers broad changes to protein ubiquitination and chromatin regulation in immune cells.

Immunofluorescence reveals DBC1 protein degradation in immune cells after inflammatory stimulus, (left) DBC1 in green in the control and (right) following LPS stimulation. Figure courtesy of Joshua Adkins.

Immune cells must respond quickly to invading pathogens. One strategy for rapid regulatory change is to alter post-translational modifications such as ubiquitination across the proteome. Adkins and colleagues (PSI MCSG in partnership with PCSEP) have taken a quantitative proteomics approach to study ubiquitination dynamics in macrophage-like murine cells upon stimulation by bacterial lipopolysaccharide (LPS), a pro-inflammatory elicitor of innate immunity.

The authors used the ubiquitin-binding domain Dsk2-UBA to enrich for modified proteins at four time points within four hours of LPS treatment, corresponding to a window of dynamic regulation assessed by western blot. Proteins were labeled using 8-plex isobaric tags for relative and absolute quantitation (iTRAQ), followed by fractionation and liquid chromatography–tandem mass spectrometry.

They detected 1,057 proteins enriched for pathways in which ubiquitinated proteins are overrepresented. Seventy-eight of those were differentially abundant between time points, among which was the deubiquitinase ataxin-3. Since ataxin-3 activity is known to be regulated by ubiquitination, the authors examined whether its ubiquitination affected the overall deubiquitinase activity of the cell: ataxin-3 activity increased slightly at four hours, linked to an increase in its own ubiquitination level and a decrease in global protein ubiquitination levels. Treating cells with proteasome inhibitor confirmed that deubiquitinases play an important role alongside protein degradation in regulating ubiquitination levels.

Leveraging prior proteomic and microarray time course data from LPS-treated cells, the researchers found proteins that appeared to be degraded after treatment, identified by a drop in protein but not in gene expression levels. An interesting member of this set is deleted in breast cancer 1 (DBC1), a histone deacetylase inhibitor that has been implicated in inflammation response in mice. Immunofluorescence and western blotting revealed that levels of a nuclear form of DBC1 are reduced after LPS treatment, while a truncated cytoplasm version stays constant. Based on proteasome and caspase inhibitor experiments, the researchers suggest a model linking inflammation to chromatin remodeling: LPS causes caspase processing and ubiquitin-mediated degradation of DBC1, which allows for the deacetylation of an acetylated form of histone 4 (H4K12ac).

This work shows that integrating data from large-scale approaches enables the study of both global regulatory patterns and the specific mechanisms of response to an inflammatory signal.

Tal Nawy


  1. E.S. Nakayasu et al. Multi-omic data integration links Deleted in Breast Cancer 1 (DBC1) degradation to chromatin remodeling in inflammatory response.
    Mol. Cell. Proteomics. 12, 2136-47 (2013). doi:10.1074/mcp.M112.026138

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health